BackGenetic Mechanisms of Cancer and Mobile DNA Elements - Nov 17
Study Guide - Smart Notes
Tailored notes based on your materials, expanded with key definitions, examples, and context.
Genetic Basis of Cancer
Normal vs. Cancerous Cells
Genetic mutations drive the transformation of normal cells into cancerous cells. The provided image compares normal colon tissue to colon cancer tissue, highlighting morphological changes due to genetic alterations.
Normal colon: Organized structure, regulated cell growth.
Colon cancer: Disorganized, excessive proliferation, loss of normal architecture.
Role of Mutations in Cancer
Mutations are central to cancer development, particularly in somatic cells.
Somatic mutations: Occur in non-reproductive cells; most cancers arise from these.
Germline mutations: Inherited mutations; contribute to cancer risk but are less common in actual cancer development.
Increased mutation rates: Cancer cells often have higher mutation rates, leading to genomic instability.
Oncogenes and Tumor Suppressors
Cancer is driven by two major classes of genes: oncogenes and tumor suppressor genes.
Oncogenes: Mutated or aberrantly expressed proto-oncogenes that promote tumor formation.
Gain-of-function alteration: Only one allele needs to be affected to trigger uncontrolled growth.
Dominant phenotype: Oncogenes confer a dominant cancer phenotype.
Tumor suppressor genes: Genes that normally inhibit tumor formation.
Loss-of-function mutations: Both alleles usually need to be inactivated.
Recessive phenotype: Tumor suppressor mutations are typically recessive.
Stages of Cancer Development
Cancer progression is multigenic and occurs in stages, with accumulation of mutations over time.
Pathways: Key genes involved include APC, Kras, and PI3K.
Stages:
Normal colonic epithelium (age 30-50)
Small adenoma (age 40-60)
Large adenoma (age 50-70)
Carcinoma (age 50-70+)
Metastasis (invasion of other tissues)
Table: Stages of Colorectal Cancer Progression
Stage | Key Mutation | Age Range |
|---|---|---|
Normal Epithelium | None | 30-50 |
Small Adenoma | APC | 40-60 |
Large Adenoma | Kras | 50-70 |
Carcinoma | PI3K, Cell Cycle/Apoptosis Genes | 50-70 |
Metastasis | Multiple | 70+ |
Evolution/Natural Selection Theory of Cancer
Cancer cells undergo selection pressures similar to natural selection:
Surveillance mechanisms: Remove mutated cells.
Escape from surveillance: Mutated cells proliferate, accumulate further mutations, and may invade other tissues (metastasis).
Inheritance and Cancer Risk
Are Cancers Inherited?
Most cancers are not directly inherited, but cancer risk can be inherited due to germline mutations in key genes.
Somatic mutations: Responsible for most cancers; not passed to offspring.
Germline mutations: Increase risk but do not guarantee cancer development.
Direct-to-consumer genetic testing: Tests for specific germline mutations (e.g., BRCA1/2).
Loss of Heterozygosity (LOH) and Tumor Suppressors
LOH is a mechanism by which tumor suppressor gene function is lost, increasing cancer risk.
Familial recessive inheritance: Both alleles must be mutated for loss of function.
LOH: Loss of the remaining normal allele in a heterozygous individual leads to tumorigenesis.
Genetic Testing and Counseling
BRCA1 Mutations and Breast Cancer Risk
BRCA1 is involved in DNA repair and genome surveillance. Mutations greatly increase breast cancer risk.
Loss-of-function mutations: 72% of women heterozygous for a BRCA1 mutation develop breast cancer (vs. 12% of women without the mutation).
Common pathogenic mutations:
185delAG in BRCA1
5382insC in BRCA1
6174delT in BRCA1
Direct-to-consumer testing: Limited to specific mutations; negative results do not rule out all risk.
Table: BRCA1 Mutations and Breast Cancer Risk
Mutation | Effect | Risk of Breast Cancer |
|---|---|---|
185delAG | Loss-of-function | 72% |
5382insC | Loss-of-function | 72% |
6174delT | Loss-of-function | 72% |
Genetic Counseling Considerations
Negative test results: Do not eliminate risk; may miss rare or untested mutations.
Importance of professional counseling: Interpretation of results and risk assessment require expertise.
Transposons: Mobile DNA Elements
Discovery and Mechanism
Transposons are DNA sequences that can move within the genome, discovered by Barbara McClintock.
Transposase: Enzyme that recognizes specific motifs and mediates transposon movement.
Autonomous vs. non-autonomous: Some transposons move independently; others require helper proteins.
Impact: Can disrupt gene function, cause mutations, and contribute to genetic diversity.
Table: Types of DNA Sequences in the Human Genome
Type | Percentage |
|---|---|
Repetitive DNA (transposable elements) | 44% |
Introns and regulatory sequences | 24% |
Unique noncoding DNA | 15% |
Repetitive DNA (unrelated to transposons) | 15% |
Exons (coding regions) | 1.5% |
Transposon Genetics in Maize
Transposons can cause visible phenotypic changes, such as color variation in maize kernels.
Genetic cross: Dominant and recessive alleles for color, with transposon-induced DNA breaks affecting expression.
Somatic movement: Transposons can move in somatic cells, causing mosaic patterns.
Breaking the Central Dogma
Flow of Genetic Information
Transposons and non-coding RNAs (ncRNAs) can disrupt the traditional flow of genetic information (DNA → RNA → Protein).
Transcription: DNA is transcribed to mRNA, rRNA, and tRNA.
Translation: mRNA is translated to protein.
ncRNA: Can regulate gene expression and interfere with the central dogma.
RNA Interference (RNAi)
Genetic Interference by Double-Stranded RNA
RNAi is a process by which double-stranded RNA silences gene expression, demonstrated in Caenorhabditis elegans.
Mechanism: Introduction of double-stranded RNA leads to degradation of target mRNA.
Applications: Used in research and potential therapies to silence disease-causing genes.
Common Features of Cancer Cells
Key Characteristics
Uncontrolled progression through cell cycle checkpoints
Chromosomal aneuploidy
Ability to invade other tissues (metastasis)
Failure to undergo apoptosis despite extensive DNA damage
Increased DNA mutation rate (not lower)
Summary Table: Cancer Genetics Concepts
Concept | Definition | Example |
|---|---|---|
Oncogene | Mutated gene promoting tumor growth | Kras |
Tumor Suppressor | Gene inhibiting tumor formation | BRCA1 |
LOH | Loss of normal allele in heterozygote | Retinoblastoma |
Transposon | Mobile DNA element | Ac/Ds in maize |
RNAi | Gene silencing by double-stranded RNA | Fire & Mello, 1998 |
Key Equations
Probability of being heterozygous for an allele: where is the frequency of the wild-type allele and is the frequency of the mutant allele.
Additional info:
Genetic counseling is essential for interpreting genetic test results and assessing cancer risk.
Transposons contribute to genome evolution and instability, with implications for disease and diversity.
RNA interference is a powerful tool for gene function studies and potential therapeutic applications.